BCAX
Bicara Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Bicara Therapeutics Inc.
8.91
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $215.4M | 10.36% | 0.00% | |
| 2 | T. Rowe Price Investment ManagementT. Rowe Price | $188.2M | 9.05% | −4.05% | |
| 3 | SirenSiren | $166.4M | 8.00% | −3.45% | |
| 4 | Vestal Point CapitalVestal Point Capital | $155.9M | 7.50% | −3.23% | |
| 5 | Deep Track CapitalDeep Track Capital | $121.7M | 5.85% | +0.92% | |
| 6 | BlackRockBlackRockindex-like | $114.2M | 5.49% | +35.32% | |
| 7 | Jupiter TopcoJupiter Topco | $94.0M | 4.52% | — | |
| 8 | Red Tree ManagementRed Tree | $93.9M | 4.52% | −0.22% | |
| 9 | TPG GP ATPG GP A | $89.4M | 4.30% | 0.00% | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $65.8M | 3.17% | +24.94% | |
| 11 | State StreetState Streetindex-like | $60.8M | 2.93% | +44.35% | |
| 12 | Franklin ResourcesFranklin Resources | $58.0M | 2.79% | +20.37% | |
| 13 | T. Rowe Price AssociatesT. Rowe Price | $56.5M | 2.72% | +38.37% | |
| 14 | FMRFMR | $56.2M | 2.70% | −9.89% | |
| 15 | Omega Fund ManagementOmega Fund | $54.1M | 2.60% | −23.83% | |
| 16 | Geode Capital ManagementGeodeindex-like | $34.5M | 1.66% | +39.92% | |
| 17 | JPMorgan ChaseJPMorgan Chase | $29.8M | 1.43% | new | |
| 18 | Jones Hill CapitalJones Hill Capital | $26.5M | 1.27% | −29.16% | |
| 19 | Acorn Capital AdvisorsAcorn Capital | $19.1M | 0.92% | 0.00% | |
| 20 | Aisling Capital ManagementAisling | $16.9M | 0.81% | 0.00% | |
| 21 | Palo Alto InvestorsPalo Alto Investors | $16.3M | 0.79% | 0.00% | |
| 22 | Rock Springs Capital ManagementRock Springs | $15.9M | 0.76% | +9.44% | |
| 23 | Goldman Sachs GroupGoldman Sachs | $15.5M | 0.74% | −6.87% | |
| 24 | D. E. ShawD. E. Shaw | $14.8M | 0.71% | +79.89% | |
| 25 | Dimensional Fund AdvisorsDimensional | $13.7M | 0.66% | +322.59% |
175 managers report $2.1B of Bicara Therapeutics on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; RA Capital Management is largest at 10.36%.
Expected move
Inputs8Q avg ±5.9%·×3.36·rich
straddle ±34.9%
spot 9.13exp Nov 20ATM strike 10ATM straddle 3.75IV 204%